Home / Private raises / Alkeon Innovation Series, LP - Omicron
Alkeon Innovation Series, LP - Omicron
Private Equity Fund · New York, New York · $51.8M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | D (new) | $51.8M | Open-ended | 54 | 506(b), 3(c), 3(c)(7) | Equity, Fund interests, Limited Partner Interests | Oct 30 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Sold through (placement agents)
| Broker-dealer | Solicited in |
|---|---|
| Oppenheimer & Co. Inc. | All States |
No sales commission reported in the latest filing.
Issuer
| Industry | Pooled Investment Fund |
| Fund type | Private Equity Fund |
| Located | New York, New York |
| Entity | Limited Partnership |
| Incorporated | Delaware, 2026 |
| Minimum investment | $1.0M |
| SEC CIK | 2164195 |
People named in the latest filing
| Name | Role |
|---|---|
| - Alkeon Innovation Series GP, LLC | General Partner |
| - Alkeon Capital Management, LLC | Manager of Alkeon Innovation Series GP, LLC, the General Partner |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
